Effects of Sufentanil on the Intraoperative Hemodynamics

Recruiting now · Not applicable

Conditions studied: Intraoperative Hypotension

In brief

This study is a randomized, controlled trial. A total of 92 patients will be randomized to receive sufentanil or remifentanil during extracranial-intracranial bypass surgery.

Key facts

Study ID

NCT06091904

Run by

Seoul National University Hospital

People needed

92

Starts

2023-11-24

Expected to finish

2026-11-01

Last updated by the study team

2025-09-16

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who undergo elective extracranial-intracranial bypass surgery
• American Society of Anesthesiologists grade 1,2,3
• Age > 18 years old

You may not qualify if…

• Refuse to participate to the study
• American Society of Anesthesiologists grade 4
• Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
• Allergic history of opioid
• pregnant
• MAO Inhibitor user
• Severe respiratory insufficiency

Where it is running

• Seoul National University Bundang Hospital — Seongnam-si, Gyeonggi-do, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.